Ketone ester supplementation reduces age-associated B cell activation in aged mice without impairing antibody responses

As we grow older, our immune system undergoes a slow, quiet transformation. It becomes less efficient at fighting new infections and less responsive to vaccines, while simultaneously becoming more prone to turning against the body itself. This internal conflict is partly driven by a specific group of immune cells that accumulate with age. These cells, known as age-associated B cells, act like overzealous security guards that have forgotten their training; instead of waiting for a real threat, they begin to attack the body's own tissues and release inflammatory signals that damage healthy organs. For decades, scientists have searched for a way to calm this internal noise without shutting down the immune system's ability to fight genuine invaders. One promising avenue involves the body's own fuel sources. When we fast or eat very few carbohydrates, our bodies switch from burning sugar to burning fat, producing small molecules called ketones that serve as an alternative energy source. These ketones are known to have anti-inflammatory properties, but until now, it was unclear whether they could specifically target these rogue immune cells in the elderly without weakening the body's overall defense.

Researchers at the Buck Institute for Research on Aging set out to test this idea using a method that mimics the effects of a ketogenic diet without requiring the strict food restrictions that are often difficult for older adults to maintain. They fed a group of nineteen-month-old mice, which is considered advanced age for a rodent, a special diet supplemented with a ketone ester for fifteen weeks. This compound is a synthetic version of the natural ketone bodies the body produces, designed to be easily absorbed and converted into fuel. The goal was to see if this dietary change could reset the behavior of the aging immune system. The team focused their attention on the spleen, a major organ where immune cells are stored and trained, looking specifically at how these cells reacted to the new fuel source.

The results revealed a striking and selective effect. The mice on the ketone ester diet showed a significant reduction in the activity of their B cells, particularly the problematic age-associated group. These cells, which typically display markers of high alert and aggression, appeared much calmer in the treated mice. They expressed fewer of the surface proteins that signal they are ready to attack, and their numbers were lower than in the mice eating a standard diet. Crucially, this calming effect did not come at the cost of the immune system's ability to protect the body. When the researchers vaccinated the mice with a harmless protein to test their immune response, the treated mice produced antibodies just as effectively as the control group. This finding is vital because it suggests that the ketone diet can quiet the chronic, damaging inflammation of aging without blunting the immune system's ability to learn and respond to new threats.

To understand how this happened, the scientists looked deeper into the cells' internal machinery. They discovered that the ketone ester diet changed how these immune cells used energy. Specifically, the cells became less dependent on glucose, the sugar that most cells burn for fuel, and showed a reduction in the rate at which they built new proteins. This slowdown in protein production was driven by the ketone bodies themselves. When the researchers took immune cells from older mice and added a ketone body directly to the culture, the cells immediately reduced their protein-making activity. This confirmed that the effect was a direct result of the ketone molecules interacting with the cells, rather than a side effect of the diet changing the mice's weight or general health. The ketone bodies appeared to act as a brake on a specific signaling pathway that controls cell growth and activation, effectively telling the overactive cells to stand down.

The study also uncovered a link to a specific protein inside the cells called T-bet, which acts as a master switch for the autoimmune behavior of age-associated B cells. In the laboratory, when the researchers treated these cells with high concentrations of the ketone body, the levels of T-bet dropped significantly. Since T-bet is responsible for driving the cells to produce harmful antibodies and inflammatory signals, reducing its presence offers a clear explanation for why the cells became less aggressive. While the concentration of ketones used in the lab dish was higher than what was measured in the blood of the mice, the fact that the diet successfully lowered cell activation in the living animals suggests that this mechanism is at work in the body, even if the exact chemical pathway is complex.

This research provides a new perspective on how we might manage the immune system in later life. It demonstrates that it is possible to target the specific cells that cause age-related inflammation while leaving the rest of the immune defense intact. The ketone ester did not act as a general sedative that put the entire immune system to sleep; instead, it acted with precision, dampening the specific cells that had become dangerous with age. The findings suggest that ketone esters could be a viable strategy for improving immune health in older adults, potentially offering a way to reduce the risk of autoimmune diseases and chronic inflammation without compromising the ability to fight off infections. While more work is needed to see if these results translate directly to humans, the study offers a compelling glimpse into how a simple change in fuel source could help restore balance to the aging body.